Clinical Trials in Maryland

Showing 10841-10860 of 23,284 trials

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

NCT01351766

The primary purpose of this study is to develop a specialized behavioral activation treatment for smoking in youths ages 18-21 with elevated depressive symptoms. In the first phase we utilize focus groups and pilot testing with 15 youths to develop the behavioral activation smoking treatment for youth. In Phase II, we will conduct an open-label trial of the new treatment that will include 8 weeks of transdermal nicotine patch, which will begin at the time of quitting smoking. Participants will be followed over 26 weeks post-quit date. A subset of participants will also undergo an fMRI session to examine reward sensitivity.

Smoking

University of Maryland, College Park39 participantsStarted Apr 2010

College Park, Maryland, United States

COMPLETEDNA9.2 miles

Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa

NCT03529409

The purpose of this study is to test the effectiveness and implementation of a brief, integrated behavioral intervention for HIV medication adherence and substance use in the HIV care setting in South Africa. The intervention is specifically designed to be implemented by non-specialist counselors using a task sharing model in local HIV clinics. The behavioral intervention will be compared to usual care, enhanced with referral to a local outpatient substance use treatment program (Enhanced Standard of Care - ESOC) on study endpoints (as described in study endpoint section below).

Human Immunodeficiency VirusAlcohol-Related DisordersDrug Use

University of Maryland, College Park66 participantsStarted Jul 2018

College Park, Maryland, United States • Cape Town, South Africa

COMPLETED12 miles

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

NCT02953704

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

MPN (Myeloproliferative Neoplasms)

Incyte Corporation1,469 participantsStarted Dec 2016

Huntsville, Alabama, United States • Tempe, Arizona, United States • Tucson, Arizona, United States +113 more locations

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Find Trials by Condition in Maryland

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

Struvite Stones Antibiotic Study

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)

EndoPredict® Extended Endocrine Trial (EXET)

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

Gene Transfer Clinical Study in Crigler-Najjar Syndrome

Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)

A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Child HCAHPS: Automated Day of Discharge Survey

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)